RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jaguar Health Stock

Jaguar Health EBIT 2024

Jaguar Health EBIT

-28.17 M USD

Ticker

JAGX

ISIN

US47010C4096

WKN

A2PLYX

In 2024, Jaguar Health's EBIT was -28.17 M USD, a -16.94% increase from the -33.92 M USD EBIT recorded in the previous year.

The Jaguar Health EBIT history

YEAREBIT (undefined USD)
2028e-
2027e105.67
2026e45.19
2025e-21.85
2024e-28.17
2023-33.92
2022-34.42
2021-39.07
2020-21.3
2019-24.3
2018-25.61
2017-15.12
2016-13.59
2015-12.45
2014-7.9
2013-0.78

Jaguar Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jaguar Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jaguar Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jaguar Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jaguar Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jaguar Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jaguar Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jaguar Health’s growth potential.

Jaguar Health Revenue, EBIT and net profit per share

DateJaguar Health RevenueJaguar Health EBITJaguar Health Net Income
2028e389.44 M undefined0 undefined0 undefined
2027e204 M undefined105.67 M undefined0 undefined
2026e26.74 M undefined45.19 M undefined-16.87 M undefined
2025e18.55 M undefined-21.85 M undefined-24.6 M undefined
2024e12.92 M undefined-28.17 M undefined-7.35 M undefined
20239.76 M undefined-33.92 M undefined-41.3 M undefined
202211.96 M undefined-34.42 M undefined-47.45 M undefined
20214.34 M undefined-39.07 M undefined-52.6 M undefined
20209.39 M undefined-21.3 M undefined-38.65 M undefined
20195.78 M undefined-24.3 M undefined-44.73 M undefined
20184.42 M undefined-25.61 M undefined-32.15 M undefined
20174.36 M undefined-15.12 M undefined-21.97 M undefined
2016142,000 undefined-13.59 M undefined-14.73 M undefined
2015258,000 undefined-12.45 M undefined-16.64 M undefined
20140 undefined-7.9 M undefined-9.26 M undefined
20130 undefined-778,000 undefined-801,000 undefined

Jaguar Health stock margins

The Jaguar Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jaguar Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jaguar Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jaguar Health's sales revenue. A higher gross margin percentage indicates that the Jaguar Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jaguar Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jaguar Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jaguar Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jaguar Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jaguar Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jaguar Health Margin History

Jaguar Health Gross marginJaguar Health Profit marginJaguar Health EBIT marginJaguar Health Profit margin
2028e79.13 %0 %0 %
2027e79.13 %51.8 %0 %
2026e79.13 %169 %-63.1 %
2025e79.13 %-117.76 %-132.59 %
2024e79.13 %-218.1 %-56.91 %
202379.13 %-347.51 %-423.11 %
202283.11 %-287.85 %-396.91 %
202146.18 %-901.36 %-1,213.26 %
202065.05 %-227 %-411.81 %
201933.92 %-420.76 %-774.48 %
201837.36 %-580 %-727.94 %
201779.82 %-346.71 %-503.76 %
201663.38 %-9,567.61 %-10,376.06 %
201552.33 %-4,823.64 %-6,448.84 %
201479.13 %0 %0 %
201379.13 %0 %0 %

Jaguar Health Aktienanalyse

What does Jaguar Health do?

Jaguar Health Inc. is a biopharmaceutical company based in San Francisco, California, focused on the development and commercialization of innovative plant-based medicines. The company's history dates back to the founding of Napo Pharmaceuticals in 2002, which was renamed Jaguar Animal Health in 2007 to focus on the development of animal medicines. In 2015, Jaguar Health then established a subsidiary named Napo Pharmaceuticals to focus on the development of plant-based medicines for human use. Jaguar Health's business model is based on the research and development of medicines derived from plant extracts, particularly from the rainforest region in South America. The company collaborates with local communities and government agencies to ensure sustainable use of these plant resources. An important aspect of the business model is also cooperation and partnership with other companies and organizations to accelerate research and development and facilitate the market launch of new medicines. Jaguar Health is divided into different divisions that focus on specific medical applications. One important division is HIV/AIDS research, where the company is investigating various plant extracts that can alleviate symptoms of the disease and inhibit the spread of the virus. Another division is oncology research, in which Jaguar Health is working on the development of plant-based compounds that can inhibit the growth of tumor cells and improve the quality of life for cancer patients. A particular focus of Jaguar Health is also the research of plant-based medicines for the treatment of gastrointestinal diseases. The company has already developed the drug Mytesi based on the Croton lechleri tree, which is used to treat diarrhea in HIV/AIDS patients. Mytesi was approved by the US Food and Drug Administration (FDA) in 2016 and is the first drug developed by the company to market. Other products and medicines that Jaguar Health is working on include the drug Canalevia for the treatment of gastrointestinal inflammation in dogs and cats, as well as the drug Neonorm, which aims to improve intestinal mobility in foals and other animal species. Overall, Jaguar Health is working on a wide range of plant-based medicines and compounds for the treatment of various diseases and ailments. The company relies on close collaboration with government agencies, local communities, and other companies to accelerate the development and commercialization of innovative medicines while ensuring sustainable use of natural resources. Jaguar Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Jaguar Health's EBIT

Jaguar Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Jaguar Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Jaguar Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Jaguar Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Jaguar Health stock

How much did Jaguar Health achieve in EBIT for the current year?

In the current year, Jaguar Health has achieved an EBIT of -28.17 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Jaguar Health.

How has the EBIT of Jaguar Health developed in recent years?

The EBIT of Jaguar Health has increased by -16.945% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Jaguar Health?

The EBIT of Jaguar Health is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Jaguar Health pay?

Over the past 12 months, Jaguar Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jaguar Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Jaguar Health?

The current dividend yield of Jaguar Health is .

When does Jaguar Health pay dividends?

Jaguar Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Jaguar Health?

Jaguar Health paid dividends every year for the past 0 years.

What is the dividend of Jaguar Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Jaguar Health located?

Jaguar Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jaguar Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jaguar Health from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Jaguar Health pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Jaguar Health in the year 2023?

In the year 2023, Jaguar Health distributed 0 USD as dividends.

In which currency does Jaguar Health pay out the dividend?

The dividends of Jaguar Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Jaguar Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Jaguar Health

Our stock analysis for Jaguar Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jaguar Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.